Delivery Order SPE2DR25D2108-SPE2DR26F6SA6
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with a completion date of June 23, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is...
- The Defense Logistics Agency awarded a $11,125.18 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 18, 2025, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,690.57 and an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $37,147.34 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 28, 2025. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,710.68 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens. This competitive, firm fixed-price delivery order is scheduled for ultimate completion on January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $31,730.30 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $12,054.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on December 29, 2025, with completion scheduled for December 30, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,721.04 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6SA6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,874.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 7, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026, with performance occurring at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2031. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains through open competition. This delivery order for Zepbound, a diabetes medication, exemplifies the company's role in providing specialized pharmaceutical products to support Department of Defense healthcare requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 1/6/26 |